Economic Implications of Preventing Major Cardiovascular and Limb Events with Rivaroxaban plus Aspirin in Patients with Coronary or Peripheral Artery Disease in the United States

nork Hernandez, Luis, Shah, Anshul, Zhao, Qi, Milentijevic, Dejan, Kharat, Akshay
Argitaratua izan da Am Health Drug Benefits (2020)

Budgetary Impact of Adding Riociguat to a US Health Plan for the Treatment of Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension

nork Burudpakdee, Chakkarin, Shah, Anshul, Joish, Vijay N., Divers, Christine H., Yaldo, Avin
Argitaratua izan da Am Health Drug Benefits (2014)

Systematic literature review of treatments for management of complications of ischemic central retinal vein occlusion

nork Bradshaw, Steven E., Gala, Smeet, Nanavaty, Merena, Shah, Anshul, Mwamburi, Mkaya, Kefalas, Panos
Argitaratua izan da BMC Ophthalmol (2016)

Cost-Effectiveness Analysis of Vedolizumab Compared with Other Biologics in Anti-TNF-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan

nork Hernandez, Luis, Kuwabara, Hiroyo, Shah, Anshul, Yamabe, Kaoru, Burnett, Heather, Fahrbach, Kyle, Koufopoulou, Maria, Iwakiri, Ryuichi
Argitaratua izan da Pharmacoeconomics (2019)